OOIR: Observatory of International Research

Papers

(The TQCC of Current Opinion in Oncology is 5. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-11-01 to 2025-11-01.)

Article	Citations
Neoadjuvant immunotherapy in melanoma: pathological response as a surrogate endpoint?	50
Is there still a place for lymph node dissection for stage III melanoma since the approval of adjuvant therapy	38
The role of signaling lymphocyte activation molecule family receptors in hematologic malignancies	30
Harnessing dendritic cells for innovative therapeutic cancer vaccines	26
Content features and its implementation in novel app-based psycho-oncological interventions for cancer survivors: a narrative review	24
Progress in diagnosis and treatment of checkpoint inhibitor pneumonitis	24
Role of PSMA PET/CT in imaging and management of prostate cancer	21
Neurorehabilitation in brain tumours: evidences and suggestions for spreading of knowledge and research implementation	21
Collecting information from all sarcoma reference cancer centres worldwide: achievement and next steps	20
Editorial introductions	18
Treatments and challenges in advanced prostate cancer	18
State of the art and upcoming trends in HER2-directed therapies in gastrointestinal malignancies	18
First and further-line multidisciplinary treatment of retroperitoneal sarcomas	17
Psycho-oncology interventions focusing on fatigue and sleep disturbances	16
Editorial introductions	15
Epigenetic dynamics of aging and cancer development: current concepts from studies mapping aging and cancer epigenomes	15
Can we yet use tertiary lymphoid structures as predictive biomarkers for immunotherapy response in melanoma?	14
State-of-the-art and trends in fibroblast growth factor receptor-directed therapies in gastro-intestinal malignancies	14
Impact of sentinel node use in lymphedema formation among gynecologic cancer patients	14
Safety of assisted reproductive techniques in gynecological cancer patients	14
New hopes in relapsed refractory primary central nervous system lymphoma	14
Editorial introductions	14
Beyond ‘the good, the bad and the ugly’: let us put rectal cancer patients at the centre of the decision making	13
Neoadjuvant and adjuvant approaches in gastroesophageal cancers	13
Local treatment in patients with hereditary breast cancer: decision-making process in low-, moderate-, high-penetrance pathogenic germline mutation carriers	13

How to prevent human papillomavirus-related oropharyngeal cancer?	13
WHO 2021 and beyond: new types, molecular markers and tools for brain tumor classification	12
Indications and technique of minimally invasive surgery in early-stage cervical cancer	12
Biomarkers and immunotherapy: where are we?	12
Editorial introductions	12
Editorial introductions	11
Enhancing proactive life-sustaining treatment preference documentation in advanced cancer care: barriers and recommendations	11
Controversies in central nervous system prophylaxis of high-risk diffuse large B-cell lymphoma	11
Open questions on vorasidenib	11
Melanoma with genetic alterations beyond the BRAF V600 mutation: management and new insights	11
Pregnancy-related hormonal changes and thyroid growth: do they have an impact on the higher incidence of differentiated thyroid cancer in women?	11
A meta-analysis of the efficacy and toxicity of tyrosine kinase inhibitors in treating patients with different types of thyroid cancer: how to choose drugs appropriately?	10
Multiple endocrine neoplasia type 2: towards a risk-based approach integrating molecular and biomarker results	10
Recent advances in precision medicine for acute myeloid leukemia	10
Immunomodulation for hepatocellular carcinoma therapy: current challenges	10
Antibody–drug conjugates in rare genitourinary tumors: review and perspectives	10
State-of-the-art and upcoming trends in RAS-directed therapies in gastrointestinal malignancies	10
Liquid biopsy in brain tumors: moving on, slowly	10
Circulating tumor DNA in breast cancer: a biomarker for patient selection	10
Dyadic psychosocial interventions for patients with cancer and their caregivers: an update	10
Lung cancer screening in never smokers	9
Editorial introductions	9
Current evidence of integrative oncology modalities for managing adverse effects and survivorship issues among adolescents and young adult (AYA) cancer patients and survivors	8
The role of genetic testing in prostate cancer screening, diagnosis, and treatment	8
The 5T's of health disparities in multiple myeloma in Latin America	8
Desmoid tumors: who, when and how to treat?	8
Interventions aiming to improve advance care planning uptake in oncology: a scoping review of recent randomized controlled trials	8
Targeting the DNA damage response beyond poly(ADP-ribose) polymerase inhibitors: novel agents and rational combinations	8
Biochemically recurrent prostate cancer in the era of EMBARK and PSMA PET imaging: everything has changed, except the patients	8
Machine learning applications and challenges in graft-versus-host disease: a scoping review	8
A new comprehensive and stratified concept for supportive care in cancer patients	8
How to become a Multinational Association of Supportive Care in Cancer-designated center of excellence in supportive care in cancer	8
Pathology and new insights in central nervous system lymphomas	8
Hybrid magnetic resonance and PET imaging for prostate cancer recurrence	8
Application of single-port techniques in endometrial cancer	7
Advantages of robotic surgery in obese patients with endometrial cancer	7
Mind the target: programmed death ligand 1 in oesophagogastric cancers	7
New therapies for brain metastases: an update	7
Current role and indications of minimally invasive surgery in gynecologic oncology	7
State of the art and upcoming trends in claudin-directed therapies in gastrointestinal malignancies	7
Potential application of artificial intelligence in cancer therapy	7
Editorial introductions	7
Editorial introductions	7
Editorial introductions	7
Less is more in endometrial cancer (SLN, conservative treatment, radical hysterectomy, molecular classification)	7
When do I ask for a DNA methylation array for primary brain tumor diagnosis?	6
The path to personalized treatment in advanced and metastatic biliary tract cancers: a review of new targeted therapies and immunotherapy	6
Preclinical glioma models in neuro-oncology: enhancing translational research	6
Editorial introductions	6
HER2-positive breast cancer: cotargeting to overcome treatment resistance	6

Question prompt lists to improve communication between cancer patients and healthcare professionals	6
Sarcoma incidence worldwide: regional differences in histology and molecular subtypes	6
How to support parenting in patients with cancer and co-parents? From research to practice	6
Pathologic diagnosis of lung cancer – recent developments	6
Adjuvant and neoadjuvant approaches in pancreatic cancer	6
Treatment of radiation-associated angiosarcoma	6
Cellular therapies in sarcoma and other solid tumors	6
Immune checkpoint inhibitors in driver mutation-positive nonsmall cell lung cancer	6
Targeting cancer stem cell pathways for lung cancer therapy	6
Breast surgery after neoadjuvant therapy	6
Controversies on chemotherapy for early HR+/HER2− breast cancer: the role of anthracyclines and dose intensification	6
Deciphering diffuse glioma immune microenvironment as a key to improving immunotherapy results	6
Advances in the pathogenesis of FLT3-mutated acute myeloid leukemia and targeted treatments	6
Richter transformation: biological insights, diagnostic challenges and emerging therapies	5
HIV-related lymphomas	5
Neoadjuvant immune checkpoint blockade enhances local and systemic tumor immunity in head and neck cancer	5
Achievements of international rare cancers networks and consortia in the neuro-oncology field	5
Molecular oncology: what is needed to speed access to innovative therapies in clinical research?	5
Current status of phosphoinotiside-3 kinase inhibitors in blood cancers	5
Polyamine metabolism in prostate cancer	5
Precision, personalization, and quality of life for patients with lymphoma	5
How to monitor the side effects of treatments in cancer patients	5
Modeling the management of patients with human epidermal growth factor receptor 2-positive breast cancer with liquid biopsy: the future of precision medicine	5
Thymic malignancies: role of immunotherapy and novel approaches	5
Update on bi-specific monoclonal antibodies for blood cancers	5
How to treat localized Hodgkin lymphoma?	5
Surgical treatment for clinical early-stage expansile and infiltrative mucinous ovarian cancer: can staging surgeries safely be omitted?	5
Immunotherapies in non-metastatic gastrointestinal cancers	5
Therapeutic cancer vaccination against telomerase: clinical developments in melanoma	5
Editorial introductions	5
Endoscopic inguinal lymphadenectomy for vulvar cancer, is it feasible?	5
Clinical management of brain tumors in pregnancy	5
Patient-proxy agreement on health-related quality of life assessment in cancer patients	5